Rare diseases
Investigational molecules
Locations
Study of Palbociclib as an Alternative to Chemotherapy for Older Patients with High-Risk Early Breast Cancer
BelgiumStudy of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas
FranceStudy on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
BelgiumStudy of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
AustriaLong-Term Safety Study of Riliprubart in Patients with Cold Agglutinin Disease
GermanyStudy on the Effectiveness and Safety of Crovalimab for Children with Atypical Hemolytic Uremic Syndrome (aHUS)
BelgiumStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
BelgiumStudy on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
BelgiumStudy on MK-6194 for Adults with Systemic Lupus Erythematosus
FranceStudy on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency
CzechiaStudy of Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
